Personal information

Other IDs

Scopus Author ID: 57705894100

Countries

India

Activities

Collapse all

Employment (2)

SVKM's NMIMS School of Pharmacy & Technology Management, Shirpur: Shirpur, Dhule, Maharashtra, IN

2025-01-02 to present | Assistant Professor (Pharmaceutical Chemistry)
Employment
Source: Self-asserted source
Swanand Kulkarni

Central University of Punjab: Bathinda, Punjab, IN

2021-10-18 to 2024-12-31 | ICMR - Senior Research Fellow (Department of Pharmaceutical Sciences and Natural Products)
Employment
Source: Self-asserted source
Swanand Kulkarni

Education and qualifications (2)

Central University of Punjab: Bathinda, PUNJAB, IN

2021-10-09 to 2025-03-06 | Doctor of Philosophy (Pharmaceutical Sciences) (Pharmaceutical Sciences and Natural Products)
Education
Source: Self-asserted source
Swanand Kulkarni

Central University of Punjab: Bathinda, Punjab, IN

2019-07-29 to 2021-07-09 | Master in Pharmacy (Medicinal Chemistry) (Department of Pharmaceutical Sciences and Natural Products)
Education
Source: Self-asserted source
Swanand Kulkarni

Funding (1)

Discovery of Novel Medicinal Agents against Polycystic Ovarian Syndrome

2022 to 2025 | Award
Indian Council of Medical Research (New Delhi, New Delhi, IN)
Source: Self-asserted source
Swanand Kulkarni

Works (15)

Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs

Current Medicinal Chemistry
2024 | Journal article
DOI: 10.2174/0929867330666230209094738
EID:

2-s2.0-85177599086

Part of ISSN: 1875533X 09298673
Contributors: Tantra, T.; Singh, Y.; Patekar, R.; Kulkarni, S.; Kumar, P.; Thareja, S.
Source: Self-asserted source
Swanand Kulkarni via Scopus - Elsevier

Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors

Journal of Biomolecular Structure and Dynamics
2024-12-02 | Journal article
DOI: 10.1080/07391102.2023.2256885
Contributors: Yogesh Singh; Niraj Kumar; Swanand Kulkarni; Satwinder Singh; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview

Current Medicinal Chemistry
2024-10 | Journal article
DOI: 10.2174/0929867331666230914103645
Contributors: Rakesh Khator; Avadh Biharee; Neha Bhatia; Swanand Kulkarni; Yogesh Singh; Chandrabose Karthikeyan; Akhlesh Kumar Jain; Suresh Thareja
Source: check_circle
Crossref

An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors

Journal of Molecular Graphics and Modelling
2024-03 | Journal article
DOI: 10.1016/j.jmgm.2023.108695
Part of ISSN: 1093-3263
Contributors: Avadh Biharee; Yogesh Singh; Swanand Kulkarni; Kailash Jangid; Vinod Kumar; Akhlesh Kumar Jain; Suresh Thareja
Source: Self-asserted source
Swanand Kulkarni

Boron in cancer therapeutics: An overview

Pharmacology and Therapeutics
2023 | Journal article
DOI: 10.1016/j.pharmthera.2023.108548
EID:

2-s2.0-85174920399

Part of ISSN: 1879016X 01637258
Contributors: Kulkarni, S.; Bhandary, D.; Singh, Y.; Monga, V.; Thareja, S.
Source: Self-asserted source
Swanand Kulkarni via Scopus - Elsevier

Developing our knowledge of the quinolone scaffold and its value to anticancer drug design

Expert Opinion on Drug Discovery
2023 | Journal article
DOI: 10.1080/17460441.2023.2246366
EID:

2-s2.0-85168271829

Part of ISSN: 1746045X 17460441
Contributors: Singh, Y.; Bhatia, N.; Biharee, A.; Kulkarni, S.; Thareja, S.; Monga, V.
Source: Self-asserted source
Swanand Kulkarni via Scopus - Elsevier

Polycystic ovary syndrome: Current scenario and future insights

Drug Discovery Today
2023 | Journal article
DOI: 10.1016/j.drudis.2023.103821
EID:

2-s2.0-85176965834

Part of ISSN: 18785832 13596446
Contributors: Kulkarni, S.; Gupta, K.; Ratre, P.; Mishra, P.K.; Singh, Y.; Biharee, A.; Thareja, S.
Source: Self-asserted source
Swanand Kulkarni via Scopus - Elsevier

Thioether linkage chemistry: perspectives and prospects in therapeutic designing

Polymer-Drug Conjugates: Linker Chemistry, Protocols and Applications
2023 | Book chapter
Part of DOI: 10.1016/B978-0-323-91663-9.00012-6
EID:

2-s2.0-85166063783
Contributors: Singh, Y.; Kulkarni, S.; Thareja, S.
Source: Self-asserted source
Swanand Kulkarni via Scopus - Elsevier

Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors

Journal of Biomolecular Structure and Dynamics
2023-12-29 | Journal article
DOI: 10.1080/07391102.2023.2175265
Contributors: Swanand Kulkarni; Yogesh Singh; Avadh Biharee; Neha Bhatia; Vikramdeep Monga; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations

Journal of Biomolecular Structure and Dynamics
2023-11-02 | Journal article
DOI: 10.1080/07391102.2022.2126397
Contributors: Avadh Biharee; Arpita Yadav; Kailash Jangid; Yogesh Singh; Swanand Kulkarni; Devesh M. Sawant; Pradeep Kumar; Suresh Thareja; Akhlesh Kumar Jain
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer

Current Medicinal Chemistry
2023-10 | Journal article
DOI: 10.2174/0929867330666221114103924
Contributors: Neha Bhatia; Rakesh Khator; Swanand Kulkarni; Yogesh Singh; Pradeep Kumar; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors

Journal of Biomolecular Structure and Dynamics
2023-05-24 | Journal article
DOI: 10.1080/07391102.2022.2051745
Contributors: Yogesh Singh; Kulkarni Swanand Sanjay; Pradeep Kumar; Satwinder Singh; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview

Medical Oncology
2022-12-05 | Journal article
DOI: 10.1007/s12032-022-01916-4
Contributors: Pooja Ratre; Swanand Kulkarni; Sweety Das; Chengyuan Liang; Pradyumna Kumar Mishra; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Selective Estrogen Receptor Modulators (SERMs) for the Treatment of ER+ Breast Cancer: An Overview

Journal of Molecular Structure
2022-08 | Journal article
DOI: 10.1016/j.molstruc.2022.133853
Contributors: Sweety Das; Swanand Kulkarni; Yogesh Singh; Pradeep Kumar; Suresh Thareja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies

Anti-Cancer Agents in Medicinal Chemistry
2022-06 | Review | Data curation, Writing - original draft
DOI: 10.2174/1871520621666210915095421
Part of ISSN: 1871-5206
Contributors: Swanand Kulkarni; Kamalpreet Kaur; Vikas Jaitak
Source: Self-asserted source
Swanand Kulkarni
grade
Preferred source (of 2)‎
How many people are using ORCID?